ARS Pharmaceuticals, Inc. (SPRY)

Typically moves ±5.65% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-12 APPROXIMATE

Since Mar 29, 2021, ARS Pharmaceuticals, Inc. (SPRY) has reported earnings 21 times. On average the shares move ±5.65% post-earnings, with a positive reaction 28.6% of the time. Its largest post-earnings gain was +22.83% (Mar 20, 2025) and its largest decline was -15.23% (Nov 13, 2024). The next earnings report is predicted for 2026-11-12 (approximate).

Earnings reactions

How SPRY moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.65%

Positive %

28.6%

Negative %

71.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 13, 2026	☽ POST	-7.31%	open_in_new
May 15, 2026	☀ PRE	-6.43%	open_in_new
Mar 09, 2026	☀ PRE	-0.11%	open_in_new
Nov 10, 2025	☀ PRE	+0.34%	open_in_new
Aug 13, 2025	☀ PRE	-5.04%	open_in_new
May 14, 2025	☀ PRE	-9.36%	open_in_new
Mar 20, 2025	☀ PRE	+22.83%	open_in_new
Nov 13, 2024	☀ PRE	-15.23%	open_in_new
Aug 06, 2024	☽ POST	-2.2%	open_in_new
May 09, 2024	☽ POST	-0.68%	open_in_new
Mar 21, 2024	☽ POST	-3.89%	open_in_new
Nov 09, 2023	☽ POST	+8.75%	open_in_new
Aug 10, 2023	☽ POST	-0.29%	open_in_new
May 15, 2023	☀ PRE	-2.86%	open_in_new
Mar 23, 2023	☽ POST	-4.05%	open_in_new
May 12, 2022	☽ POST	-2.31%	open_in_new
Mar 31, 2022	☽ POST	-8.55%	open_in_new
Nov 10, 2021	☽ POST	+2.31%	open_in_new
Aug 12, 2021	☽ POST	+3.09%	open_in_new
May 13, 2021	☽ POST	+7.32%	open_in_new
Mar 29, 2021	☽ POST	-5.65%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.65%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 23 →

Funds holding

$121201541

Total value held

Buying

19 added · 4 reduced

Blackrock, Inc.

$42543666 +5.97%

State Street Corp

$29882290 +2.35%

Ubs Group Ag

$15536629 NEW BUY

General American Investors Co Inc

$9075698 NEW BUY

Northern Trust Corp

$4398003 +3.74%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260904	open_in_new SEC.gov
144	20260903	open_in_new SEC.gov
144	20260902	open_in_new SEC.gov
4	20260902	open_in_new SEC.gov
144	20260901	open_in_new SEC.gov
144	20260831	open_in_new SEC.gov
144	20260820	open_in_new SEC.gov
144	20260820	open_in_new SEC.gov
144	20260819	open_in_new SEC.gov
144	20260819	open_in_new SEC.gov

Frequently asked about SPRY earnings

When does ARS Pharmaceuticals, Inc. report earnings next? expand_more

ARS Pharmaceuticals, Inc. (SPRY)'s next earnings date is approximate for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does SPRY stock move after earnings? expand_more

Over 21 reports, SPRY has moved an average of ±5.65% the session after earnings, closing higher 28.6% of the time.

What was SPRY's biggest post-earnings move? expand_more

SPRY's largest post-earnings gain on record was +22.83% on Mar 20, 2025, and its largest decline was -15.23% on Nov 13, 2024.

Where can I find ARS Pharmaceuticals, Inc.'s SEC filings? expand_more

All of ARS Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.